Home
About
Overview
Sharing Data
ORCID
Help
History (59)
Copy number variation analysis in 98 individuals with PHACE syndrome.
Characterization of protein conformational states by normal-mode frequencies.
Noncytotoxic DsRed derivatives for whole-cell labeling.
Delivery of a liposomal c-raf-1 antisense oligonucleotide by weekly bolus dosing in patients with advanced solid tumors: a phase I study.
A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer.
See All 59 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer.
A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer. Ann Oncol. 1998 Oct; 9(10):1085-90.
View in:
PubMed
subject areas
Aged
Antineoplastic Agents
Camptothecin
Carcinoma, Non-Small-Cell Lung
Female
Granulocyte Colony-Stimulating Factor
Humans
Lung Neoplasms
Male
Middle Aged
Survival Analysis
Treatment Outcome
authors with profiles
Mark Ratain
Philip Hoffman